Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Return on Capital Employed (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Return on Capital Employed for 11 consecutive years, with 0.91% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 65.0% year-over-year to 0.91%, compared with a TTM value of 0.91% through Dec 2025, up 65.0%, and an annual FY2025 reading of 0.73%, up 190.0% over the prior year.
  • Return on Capital Employed was 0.91% for Q4 2025 at Neuroone Medical Technologies, down from 0.5% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.5% in Q3 2025 and bottomed at 4.06% in Q3 2024.
  • Average Return on Capital Employed over 5 years is 1.61%, with a median of 1.22% recorded in 2021.
  • The sharpest move saw Return on Capital Employed crashed -273bps in 2021, then soared 356bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.95% in 2021, then grew by 4bps to 0.91% in 2022, then tumbled by -168bps to 2.43% in 2023, then skyrocketed by 36bps to 1.56% in 2024, then skyrocketed by 42bps to 0.91% in 2025.
  • Business Quant data shows Return on Capital Employed for NMTC at 0.91% in Q4 2025, 0.5% in Q3 2025, and 0.91% in Q2 2025.